Skip to content

Buddhist Awareness Training Program and Qigong Psychosocial Interventions for People With Insomnia

Comparative Effectiveness of the Mahayana Buddhist Awareness Training Program and Qigong Intervention on the Psychological and Neurological Outcomes for People With Insomnia: A Randomized Controlled Trial

Status
Suspended
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06910423
Enrollment
86
Registered
2025-04-04
Start date
2030-01-01
Completion date
2032-12-31
Last updated
2026-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia, Randomised Controlled Trial

Keywords

Mahayana Buddhist Awareness Training Program, Electroencephalography, Qigong, Hong Kong

Brief summary

This study aims to compare the efficacy of the Mahayana Buddhist Awareness Training Program (ATP) with a Qigong group in treating people with insomnia in Hong Kong. It also aims to investigate the underlying mechanisms, including changes in brain activity and heart rate variability during wakefulness, through which these two Eastern mind body interventions improve sleep quality. It is expected that ATP will be as efficacious as Qigong in enhancing sleep quality. Compared to the Qigong intervention, the more mind-based ATP will lead to more improvement in mental health and greater reductions in hyperarousal brain activity. Compared to ATP, the more body-based Qigong will lead to greater improvement in physical health and heart rate variability.

Interventions

BEHAVIORALPsychosocial intervention

Culturally relevant psychosocial intervention for people with insomnia

Sponsors

College of Professional and Continuing Education Limited
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* (1) being a resident of Hong Kong; * (2) age between 50 and 75 years old; * (3) possessing the ability to read and write in Chinese; * (4) obtaining a Pittsburgh Sleep Quality Index (PSQI) score \> 5 at baseline * (5) demonstrating willingness to provide informed consent and adherence to study protocol.

Exclusion criteria

* (1) Beck Depression Inventory-II suicidal ideation score \>= 2; * (2) current use of hypnotic medications or any prescription medications that may influence sleep; * (3) necessity to take such medications during the trial period; * (4) ongoing therapies or clinical trials for insomnia; * (5) intention to undergo such clinical interventions during the trial period; * (6) working in shifts; * (7) engagement in considerable mindfulness practices exceeding 15 minutes per day; * (8) regular participation in different forms of Qigong, aerobics, yoga, Tai Chi, or martial arts practice at least once a week in the past six months; * (9) limited mobility or health conditions that hinder the performance of specific Qigong movements; * (10) currently receiving psychological, psychiatric or counselling services at least once a month; * (11) having been diagnosed with schizophrenia or psychosis by a clinician; * (12) having an active metal implant, pacemaker, or defibrillator in the body that affects objective assessment; * (13) impaired skin integrity or allergies to electrode gel or adhesive at the wearable EEG device placement site; * (14) pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Changes over the measurement points in the 19-item Pittsburgh Sleep Quality IndexBaseline, immediately after the intervention, 7 weeks after the interventionIt measures sleep quality and disturbances experienced within a 1-month time frame. Scores range from 0 to 21, where a higher score represents poorer sleep quality.
Changes over the measurement points in the brain activity during wakefulnessBaseline, immediately after the intervention, 7 weeks after the interventionSpectral power analysis for participants' theta (4-8 Hz), alpha (8-13 Hz), beta (13-30 Hz), and gamma (30-50 Hz) bands during a 10-minute resting state wakefulness will be measured by the UMindSleep device (http://www.eegsmart.com/en/UMindSleep.html).
Changes over the measurement points in the heart rate variabilityBaseline, immediately after the intervention, 7 weeks after the interventionThis will be measured by the same wearable UMindSleep device.

Secondary

MeasureTime frameDescription
Changes over the measurement points in the 7-item Insomnia Severity IndexBaseline, immediately after the intervention, 7 weeks after the interventionIt measures the nature, severity and impact of insomnia. Scores range from 0 to 28, where a higher score represents greater insomnia severity.
Changes over the measurement points in the 16-item Pre-Sleep Arousal ScaleBaseline, immediately after the intervention, 7 weeks after the interventionIt measures the symptoms of cognitive and somatic arousal experienced at bedtime. Scores range from 18 to 80, where a higher score represents greater pre-sleep arousal.
Changes over the measurement points in the 5-item item Santa Clara Brief Compassion ScaleBaseline, immediately after the intervention, 7 weeks after the interventionIt measures participants' perceived compassion towards others. Scores ranges from 5 to 35, where a higher score represents greater compassion towards others.
Changes over the measurement points in the PROMIS® 2-item Global Physical Health-2 ScaleBaseline, immediately after the intervention, 7 weeks after the interventionIt measures participants' perceived physical health. The raw total score will be converted to a T-score. T scores range from 23.4 to 63.3, where a higher score represents a higher perceived physical health.
Changes over the measurement points in the PROMIS® 2-item Global Mental Health-2 ScaleBaseline, immediately after the intervention, 7 weeks after the interventionIt measures participants' perceived mental health. The raw total score will be converted to a T-score. T Scores ranges from 25.8 to 64.6, where a higher score represents a higher perceived mental health.
Changes over the measurement points in the 6-item Qi Stagnation ScaleBaseline, immediately after the intervention, 7 weeks after the interventionIt measures participants' self-reported pathological qi status characterized by the slow and idle flow of qi. Scores range from 6 to 30, where a higher score represents greater qi stagnation.
Changes over the measurement points in the 6-item Qi Deficiency ScaleBaseline, immediately after the intervention, 7 weeks after the interventionIt measures participants' self-reported pathological qi status characterized by the lack of qi in one of the viscera or the whole body. Scores range from 6 to 30, where a higher score represents greater qi deficiency.
Changes over the measurement points in the 2-item Generalized Anxiety Disorder-2 ScaleBaseline, immediately after the intervention, 7 weeks after the interventionIt measures participants' anxiety level. Scores range from 0 to 6, where a higher score represents higher anxiety level.
Changes over the measurement points in the 2-item Patient Health Questionnaire-2 ScaleBaseline, immediately after the intervention, 7 weeks after the interventionIt measures participants' depression level. Scores range from 0 to 6, where a higher score represents higher depression level.

Countries

Hong Kong

Contacts

PRINCIPAL_INVESTIGATORVictoria Ka-Ying Dr. HUI, PhD

College of Professional and Continuing Education Limited

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026